Coastline Trust Co Makes New $765,000 Investment in CME Group Inc. $CME

Coastline Trust Co acquired a new stake in CME Group Inc. (NASDAQ:CME) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,800 shares of the financial services provider’s stock, valued at approximately $765,000.

A number of other institutional investors have also made changes to their positions in the company. Norges Bank purchased a new position in shares of CME Group in the second quarter valued at $1,571,447,000. Sanders Capital LLC purchased a new stake in CME Group during the 3rd quarter worth $1,006,932,000. Strive Asset Management LLC purchased a new stake in CME Group during the 3rd quarter worth $636,487,000. Mawer Investment Management Ltd. lifted its holdings in CME Group by 107.2% in the 3rd quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock worth $406,029,000 after buying an additional 777,571 shares in the last quarter. Finally, Viking Global Investors LP acquired a new position in CME Group in the 2nd quarter worth $164,648,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CME has been the subject of several recent analyst reports. Bank of America raised their target price on CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Raymond James Financial cut their price target on CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Royal Bank Of Canada increased their price target on CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a report on Thursday, February 5th. TD Cowen raised their price objective on CME Group from $305.00 to $328.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Finally, Erste Group Bank upgraded CME Group from a “hold” rating to a “strong-buy” rating in a report on Thursday, March 5th. Two research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, CME Group has a consensus rating of “Hold” and an average price target of $304.06.

Insider Activity at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 3,291 shares of the stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the transaction, the general counsel owned 7,192 shares of the company’s stock, valued at $2,397,597.04. This trade represents a 31.39% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the sale, the director owned 2,699 shares of the company’s stock, valued at $809,700. This trade represents a 21.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 8,539 shares of company stock worth $2,713,821 over the last quarter. 0.30% of the stock is owned by corporate insiders.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Goldman Sachs published a bullish forecast for CME, calling for strong price appreciation — this likely supported upside sentiment among investors. Goldman Sachs Forecasts Strong Price Appreciation for CME Group
• Neutral Sentiment: Analyst coverage remains mixed but constructive overall: multiple firms maintain buy/overweight stances and some price targets (e.g., TD Cowen, Morgan Stanley) are above the current trading level, while others (e.g., JP Morgan) are more conservative — this creates a balanced catalyst set for price discovery. Quiver Quant – Analyst ratings & price targets summary
• Neutral Sentiment: Reported short-interest data for March shows zero shares shorted (days-to-cover 0.0), but the figures look erroneous/artefactual (NaN and repeated 0 values). As reported, this offers no reliable signal on bearish positioning.
• Negative Sentiment: Insider selling: CME’s Senior MD & General Counsel Jonathan L. Marcus sold 3,291 shares (~$1.1M) on March 17, reducing his stake by ~31%. Market participants often view sizable insider sales as a short-term negative signal. SEC Form 4 – Marcus sale
• Negative Sentiment: Aggregated insider activity over recent months shows more sales than buys (multiple senior executives have sold shares), which can weigh on sentiment if investors interpret this as executives taking gains rather than signaling long-term conviction. Quiver Quant – Insider activity

CME Group Price Performance

Shares of CME stock opened at $310.71 on Friday. The firm has a fifty day moving average of $299.19 and a two-hundred day moving average of $280.13. The firm has a market cap of $112.04 billion, a P/E ratio of 27.84, a P/E/G ratio of 3.34 and a beta of 0.24. CME Group Inc. has a 1-year low of $248.53 and a 1-year high of $329.16. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.03.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the business posted $2.52 EPS. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. As a group, research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be paid a dividend of $1.30 per share. The ex-dividend date is Tuesday, March 10th. This is an increase from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 annualized dividend and a yield of 1.7%. CME Group’s payout ratio is currently 46.59%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.